ROZZINI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 7.789
AS - Asia 3.716
EU - Europa 3.529
SA - Sud America 705
AF - Africa 121
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 15.873
Nazione #
US - Stati Uniti d'America 7.660
CN - Cina 1.374
SG - Singapore 1.152
UA - Ucraina 847
BR - Brasile 578
PL - Polonia 520
IT - Italia 508
DE - Germania 504
HK - Hong Kong 410
FI - Finlandia 313
VN - Vietnam 241
FR - Francia 216
GB - Regno Unito 203
RU - Federazione Russa 137
BD - Bangladesh 127
IE - Irlanda 122
TR - Turchia 121
IN - India 103
CA - Canada 60
NG - Nigeria 60
AR - Argentina 49
MX - Messico 39
IQ - Iraq 27
SE - Svezia 27
ZA - Sudafrica 24
JP - Giappone 23
NL - Olanda 22
ID - Indonesia 21
PK - Pakistan 20
AT - Austria 19
BE - Belgio 19
EC - Ecuador 17
IR - Iran 17
VE - Venezuela 15
MA - Marocco 14
SA - Arabia Saudita 12
CO - Colombia 11
PY - Paraguay 11
UZ - Uzbekistan 11
CL - Cile 10
ES - Italia 10
CH - Svizzera 8
KR - Corea 8
CZ - Repubblica Ceca 7
EU - Europa 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
JM - Giamaica 6
JO - Giordania 6
PE - Perù 6
TW - Taiwan 6
LV - Lettonia 5
AL - Albania 4
EG - Egitto 4
KE - Kenya 4
UY - Uruguay 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
DZ - Algeria 3
HN - Honduras 3
KW - Kuwait 3
MU - Mauritius 3
MY - Malesia 3
NP - Nepal 3
PS - Palestinian Territory 3
BH - Bahrain 2
CI - Costa d'Avorio 2
GE - Georgia 2
GT - Guatemala 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
NI - Nicaragua 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BJ - Benin 1
EE - Estonia 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GR - Grecia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MN - Mongolia 1
Totale 15.863
Città #
Fairfield 974
Woodbridge 791
Ashburn 669
Singapore 598
Jacksonville 557
Warsaw 519
Houston 508
Hong Kong 409
Wilmington 375
Seattle 365
Cambridge 363
Ann Arbor 307
San Jose 262
Beijing 261
Princeton 221
Nanjing 219
The Dalles 216
Chandler 208
Helsinki 188
New York 188
Dublin 122
Brescia 121
Los Angeles 121
Istanbul 104
Lauterbourg 102
Munich 95
Milan 84
Ho Chi Minh City 81
Nanchang 72
Dallas 71
Abuja 58
Buffalo 58
Hebei 55
Des Moines 49
Moscow 48
São Paulo 48
Shanghai 46
Changsha 45
San Diego 45
Dearborn 44
Hanoi 43
Jinan 41
Tianjin 41
San Francisco 39
Shenyang 38
Redondo Beach 37
Nuremberg 30
Council Bluffs 27
Jiaxing 27
Hangzhou 26
Orem 25
Santa Clara 25
Turku 25
Kunming 23
Dong Ket 22
Chicago 21
Toronto 21
Verona 21
Montreal 20
Brussels 19
London 19
Denver 18
Zhengzhou 18
Boardman 17
Guangzhou 16
Rio de Janeiro 16
San Mateo 16
Mumbai 15
Ningbo 15
Phoenix 15
Rome 15
Augusta 14
Brooklyn 14
Lanzhou 14
Poplar 14
Ardabil 13
Frankfurt am Main 13
Johannesburg 13
Stockholm 13
Belo Horizonte 12
Manchester 12
Newton Abbot 12
Tokyo 12
Amsterdam 11
Bologna 11
Charlotte 11
Chennai 11
Jakarta 11
Mexico City 11
Tashkent 11
Atlanta 10
Boston 10
Da Nang 10
Haikou 10
Leawood 10
Baghdad 9
Osasco 9
Salò 9
Thái Bình 9
Washington 9
Totale 10.746
Nome #
Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. 351
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 349
Gene expression profile in fibroblasts of Huntington's disease patients and controls 282
Behavioral disorders in Alzheimer disease: a transcultural perspective 279
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 266
COVID-19 impact on consecutive neurological patients admitted to the emergency department 257
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors. 248
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 238
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 222
Gene expression profile in fibroblasts of Huntington's disease patients and controls. 217
Social networks and health status in the elderly: the ‘ANZIANI IN-RETE’ population-based study 210
A case report: doctor, my daughter has Alzheimer's disease. 201
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 200
The Italian version of the pain assessment in advanced dementia (PAINAD) scale 196
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 186
Depressive disorders in dementia. 183
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 183
Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer’s Disease: A Case Control Study 179
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 177
Cognitive dysfunction and age-related macular degeneration. 176
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 174
Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease. 172
Acetylcholinesterase inhibitors and depressive symptoms in patients with mild to moderate Alzheimer's disease. 168
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 168
Diagnosis disclosure and advance care planning in Alzheimer disease: opinions of a sample of Italian citizens. 166
Non-amnestic mild cognitive impairment and sleep complaints: a bidirectional relationship? 166
Impaired financial abilities in mild cognitive impairment: a direct assessment approach. 165
Gene expression profile in fibroblasts of Huntington's disease patients and controls 163
Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease. 163
Alzheimer disease and frontotemporal dementia. 160
Severe worsening of parkinsonism in Lewy body dementia due to donepezil. 160
Anxiety symptoms in mild cognitive impairment. 157
The Italian Version of the Five-Word Test: A Simple Diagnostic Test for Dementia due to Alzheimer's Disease in Routine Clinical Practice 157
Prestroke dementia: characteristics and clinical features in consecutive series of patients. 153
Free copper in serum: An analytical challenge and its possible applications 150
Behavioral syndromes in Alzheimer's disease: description and correlates. 149
Predictors of progression from mild cognitive impairment to Alzheimer disease. 149
Pre-stroke and post-stroke dementia: Preliminary data from an Italian study 148
Procedural memory stimulation in Alzheimer's disease: impact of a training programme. 147
Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment 147
Does age at observation time affect the clinical presentation of mild cognitive impairment? 146
Does reversible MCI exist? 146
Do vascular risk factors play a role in the progression of mild cognitive impairment? 144
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. 142
Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. 139
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study. 139
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study 138
Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients 136
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 134
Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. 133
Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy. 131
Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. 129
Validity of direct assessment of functional status as a tool for measuring Alzheimer's disease severity. 129
Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study 128
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease 128
Object and action naming in Alzheimer's disease and frontotemporal dementia 127
The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease. 126
The migraine-PFO connection is independent of sex. 126
Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment. 125
Alteration of APP processing in platelets and CSF of AD patients European 125
Microvascular damage and platelet abnormalities in early Alzheimer's disease. 124
Transient global amnesia and venous flow patterns. 124
Surface dyslexia in an Italian patient with semantic dementia 124
Serum albumin level interferes with the effect of donepezil in Alzheimer's disease. 123
The impact of cognitive deficit on self-reported car crashes in ultra-octogenarian population: data of an Italian population-based study. 122
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study. 121
Prevalence and demographic features of early-onset neurodegenerative dementia in Brescia County, Italy. 119
Changes in characteristics of Alzheimer patients at first visit to centers for dementia: a 10-year follow-up study. 119
Assessment of platelet Amyloid Precursor Protein forms ratio in patients with mild cognitive impairment: A tool for the identification of preclinical Alzheimer Disease 119
Spatial navigation in elderly healthy subjects, amnestic and non amnestic MCI patients 119
Acetylcholinestfrase inhibitors are effective in "real world" patients with mild to moderate Alzheimer disease: Evidence from a large population treated with rivastigmine or donepezil 117
Transient global amnesia and disturbance of venous flow patterns 117
App isoforms ratio in platelets: A peripheral marker for the diagnosis and treatment of Alzheimer's disease? 116
Transient global amnesia: a clinical and sonographic study 114
Incidence of and risk factors for hallucinations and delusions in patients with probable AD. 113
Volume reduction in cerebral blood flow in patients with Alzheimer’s disease. A sonographic study 113
Predictors of institutionalization in demented patients discharged from a rehabilitation unit 112
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 111
Efficacy of SSRI on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors 111
Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. 110
Knowledge and attitudes about Alzheimer's disease in the lay public: influence of caregiving experience and other socio-demographic factors in an Italian sample. 110
Clinical correlates of executive dysfunctions in mild cognitive impairment 108
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. 107
Parkinsonian signs in subjects with mild cognitive impairment 106
Aspetti etici delle demenze 106
Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. 103
Apolipoprotein E allele and platelets amyloid precursor protein in Alzheimer's disease: Biological effect of acetylcholinesterase inhibitors treatment 100
Depression is unrelated to conversion to dementia in patients with mild cognitive impairment. 99
Rilevazione di segnali disgrafici e grafo-patologici in un gruppo di persone affette da demenza 99
Results of a multi-level therapeutic approach for Alzheimer's disease subjects in the "real world" (CRONOS project): a 36-week follow-up study 98
Peripheral oedema related to quetiapine therapy : a case report. 96
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study 92
Short-term memory binding in mild cognitive impairment: a preclinical marker of Alzheimer's disease? 92
Platelet Amyloid Precursor Protein ratio as a biochemical marker for Alzheimer disease: Sensitivity and specificity 89
Predictors of recurence in paradoxical cerebral embolism 89
Vascular risk factors for VaD and AD in a population-based prospective cohort. The PAQUID study 88
Retrograde jugular venous flow is a predisposing factor in transient global amnesia. 87
L’Istituto di Riabilitazione Geriatrica (IDRG): un modello clinico-assistenziale per le demenze? 84
Il progetto Cronos e le Unità di Valutazione Alzheime 83
La depressione dell'anziano: un rilevante fattore di modulazione prognostica 82
Totale 14.719
Categoria #
all - tutte 70.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202171 0 0 0 0 0 0 0 0 0 0 0 71
2021/2022859 39 198 9 39 7 36 53 56 50 101 55 216
2022/2023691 129 21 12 35 65 207 6 61 91 4 25 35
2023/2024740 48 25 73 43 21 123 29 26 213 13 9 117
2024/20251.963 10 22 22 268 239 169 222 53 213 117 402 226
2025/20264.251 355 551 315 638 354 308 634 198 236 343 191 128
Totale 16.047